Application YC di FidoCure®

Winter 2018Active

FidoCure® ha partecipato a Y Combinator nel batch Winter 2018 come azienda Healthcare. Sotto: cosa fa l'azienda, chi l'ha fondata e la sua application a YC, ricostruita domanda per domanda nel form reale di YC.

Batch YC: Winter 2018
Settore: HealthcareHealthcare Services
Dimensione team: 14
Stato: Active
Lanciata: 2018

Founder

christina lopesFounder

Cosa fa FidoCure®

Cancer is a genetic disease. We know this from decades of human and veterinary cancer research. Precision medicine and targeted therapies are successfully used to treat humans with cancer. At FidoCure®, we bring this approach to the world of veterinary medicine. FidoCure® empowers veterinarians to offer genetic sequencing and targeted therapies to treat dogs with cancer. We are committed to expanding the veterinary oncology toolbox for both diagnostics and therapeutics. Our veterinary partners have treated thousands of dogs over the past 30 years and work closely with the growing FidoCure® network of over 143 clinics and 180 forward-thinking veterinary oncologists throughout the US. Together, we can combat canine cancer!

Application YC di FidoCure®, ricostruita

Domanda per Y Combinator

FidoCure®, batch Winter 2018. Le vere domande del form, risposte da dati pubblici.

Founders2
Company7
Progress7
Idea4
Equity3
Curious2
Batch Preference1

Company

Company name

FidoCure®

Describe what your company does in 50 characters or less.

Precision medicine for canine cancer

What is your company going to make? Please describe your product and what it does or will do.

We built a platform that offers genetic sequencing and targeted therapies for dogs with cancer. Veterinarians use our service to identify the genetic mutations driving each dog's cancer and get tailored treatment options. This improves treatment effectiveness in canine oncology where options have been limited.

Where do you live now, and where would the company be based after YC?

We live in Palo Alto, CA and have a remote team. Post-YC, the company will continue to be based in Palo Alto with distributed staff.

Explain your decision regarding location.

Palo Alto is fertile ground for healthcare tech talent and close to experts in precision medicine. Being remote lets us tap talent nationwide while maintaining headquarters in a key innovation hub.

21 risposte in più nell'application completa

Founders, Progress, Idea, Equity, Curious, Batch Preference sono nella versione completa. Crea un account gratuito per aprirla in YC Insights, accanto a ogni altro batch YC.

Vedi domanda completa

Domande Frequenti

Questa è l'application YC reale di FidoCure®?

No. Y Combinator mantiene private le application inviate. Questa è una ricostruzione: le domande del form YC reale, a cui si è risposto usando i dati pubblici di FidoCure® (note di lancio, background dei founder, descrizione del prodotto). Mostra come un'azienda come FidoCure® si presenterebbe a YC, non il testo che hanno inviato.

A quale batch YC apparteneva FidoCure®?

FidoCure® apparteneva al batch Winter 2018 di Y Combinator.

Chi ha fondato FidoCure®?

FidoCure® è stato fondato da christina lopes.

Cosa fa FidoCure®?

FidoCure® is the leader in Precision Medicine for Canine Oncology.

Come leggo la ricostruzione completa della application?

Crea un account Round Funded gratuito. La versione completa di 26 risposte della application di FidoCure®, e di ogni altro batch YC, è in YC Insights.